Clinical Trial Update: Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 withdrawal study of memantine in pediatric patients with autism spectrum disorders after prior memantine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asperger Disorder
• Asperger Syndrome
• Autism Spectrum Disorder
• Autism Spectrum Disorders
• Autistic Disorder
• Pervasive Developmental Disorder - Not Otherwise Specified

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Forest Laboratories | Conditions: Autistic Disorder, Autism | Phase 2 | Status: COMPLETED | Results posted: 2019-04-24